Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 12/14: (AKBA) (DEST) (TSL) Higher; (ATRA) (NWL) (GPRO) Lower (more...)

December 14, 2015 9:33 AM
Atara Biotherapeutics, Inc. (Nasdaq: ATRA) 42.8% LOWER; announced results from its Phase 2 proof-of-concept clinical trial for PINTA 745 for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles